BRISTOL-MYERS SQUIBB COMPANY
NL
Background
Career
BS
WASHINGTON, DC · current
Government experience
Director/Advisor-Senate Finance Committee 2018-2025; Comms Dirctor
U.S.House 2015-2018
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATE
Specific issues
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.7391, CHC Drug Pricing Protection Act H.R.5509, Safe Step Act Issues related to biosimilars reimbursement issues Clinical Trial Modernization Act Essential medicines/Buy American regarding all bio-pharmaceutical provisions
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →